Corvus Pharmaceuticals, Inc.

CRVS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$2,867$14,691$4,999$8,740
Short-Term Investments$62,822$59,716$39,213$43,224
Receivables$32$259$227$216
Inventory$0$0$0$0
Other Curr. Assets$1,223$1,114$1,052$2,227
Total Curr. Assets$66,944$75,780$45,491$54,407
Property Plant & Equip (Net)$1,148$1,261$1,260$1,328
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$11,530$11,794$12,058$12,540
Tax Assets$0$0$0$0
Other NC Assets$852$626$629$632
Total NC Assets$13,530$13,681$13,947$14,500
Other Assets$0$0$0$0
Total Assets$80,474$89,461$59,438$68,907
Liabilities
Payables$1,974$3,137$1,308$2,582
Short-Term Debt$379$355$319$185
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,721$5,013$7,652$32,635
Total Curr. Liab.$8,074$8,505$9,279$35,402
LT Debt$632$728$834$937
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$632$728$834$937
Other Liabilities$0$0$0$0
Cap. Leases$1,011$1,083$1,153$1,122
Total Liabilities$8,706$9,233$10,113$36,339
Equity
Pref Stock$0$0$0$0
Common Stock$7$7$7$7
Retained Earnings-$399,972-$389,815-$381,817-$397,010
AOCI-$1,060-$1,148-$1,254-$1,288
Other Equity$472,793$471,184$432,389$430,859
Total Equity$71,768$80,228$49,325$32,568
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$80,474$89,461$59,438$68,907
Net Debt-$1,856-$13,608-$3,846-$7,618
Corvus Pharmaceuticals, Inc. (CRVS) Financial Statements & Key Stats | AlphaPilot